White subjects with AO (waist circumference >94 cm for men and >80 cm for women) 2 aged 40 to 65 years and age-and sex-matched healthyAbstract-Incidence and prevalence of abdominal obesity (AO) are growing exponentially. Subjects with AO are at higher risk of developing heart failure. The purpose of the study was to investigate early changes in cardiac and arterial structure and function and extracellular matrix biomarkers in normotensive healthy subjects with AO. Subjects with AO and age-and sex-matched controls underwent echocardiography, MRI (cardiac remodeling index), carotid intima-media thickness, pulse wave velocity, and blood fibrosis biomarkers measurements. We enrolled 87 subjects with AO and 53 controls. Although normotensive, subjects with AO had higher systolic blood pressure (BP; 122±11 versus 116±11 mm Hg; P=0.003), left ventricular mass (94±24 versus 84±21 g; P=0.034), and cardiac remodeling index (0.67±0.16 versus 0.60±0.10 g/mL; P=0.026) but unchanged carotid intima-media thickness and pulse wave velocity. Diastolic dysfunction (E′ <10 cm/s) could be detected in 38% of subjects with AO (4% in controls). Left ventricular remodeling, as assessed by cardiac remodeling index, was positively and independently associated with higher BP (systolic BP and mean arterial pressure but not diastolic BP) and AO. Higher BP, AO, and procollagen-III-N-terminal peptide (≥2.4 ng/mL) concentrations (odds ratio, 4.15 [1.42-12.2]; P=0.01) were positively associated with diastolic dysfunction. Early cardiac structural remodeling, fibrosis, and diastolic dysfunction were detectable in healthy subjects with AO. Higher BP, procollagen-III-N-terminal peptide, and AO were independently associated with early cardiac structural and functional changes. It is to be investigated whether in subjects with AO, an early BP reduction, even if normotensive, combined with weight loss may avoid adverse cardiac remodeling and protect against progression to heart failure. From the INSERM, Center d'Investigation Clinique CIC-P 9501, Nancy, France (R.E., P.R., A.K.S., C.A., K.K., R.F., F.Z.); CHU-Nancy, Department of Cardiology, Nancy, France (F.Z.); Université de Lorraine, Nancy, France (P.R., D.M., P.Y.M., F.Z.); INSERM, U1116, Nancy, France (P.R., P.Y.M., F.Z.); Clermont Université, Université d'Auvergne, UMR6284, Clermont-Ferrand, France (R.E.); CHU Clermont-Ferrand, Department of Cardiology, ClermontFerrand, France (R.E.); CHU-Nancy, Department of Radiology, Nancy, France (D.M.); CHU-Nancy, Department of Nuclear Medicine, Nancy, France (P.Y.M.); and INSERM, U947, Nancy, France (D.M.
Metabolic PhenotypingBlood was sampled between 8 and 10 am after maintaining a supine position for 30 minutes and the following were assessed: fasting glucose, oral glucose tolerance test (to exclude patients with diabetes mellitus), glycohemoglobin, serum creatinine (estimated glomerular filtration rate by the MDRD [Modification of the Diet in Renal Disease] formula), 9 ultrasensitive C-reactive protein, alanine aminotransferase, lipid profile, leptin, ...